2 Potential Headwinds and 2 Potential Tailwinds for InMode Stock in August

InMode's (NASDAQ: INMD) shares are down around 60% so far this year, and its shareholders are having a very bumpy ride. However, it might not be difficult much longer. The medical-device manufacturer will report earnings for the second quarter on July 28, and all eyes are going to be on how it's navigating the stormy waters of the global economy.

The trouble is, there's so much going on that the company's stock is liable to be impacted by multiple forces. Some will support its growth and others will pressure its returns downward. Let's analyze the most important issues facing InMode right now to get a sense of how these factors might play out over the rest of the year and beyond.

InMode develops devices that plastic surgeons and medical aestheticians use to provide outpatient and relatively non-invasive beauty treatments like skin tightening, muscle toning, and fat-deposit liquidation. The advantage of its systems are that they're less invasive than plastic surgery, so it's easier to get patients to commit to being treated.

Source Fool.com